LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $212 | -99.9% | 2,945 | -23.0% | 0.02% | -74.6% |
| Q3 2020 | $365,000 | -2.1% | 3,827 | +14.6% | 0.06% | +46.5% |
| Q2 2020 | $373,000 | +30.4% | 3,339 | +21.6% | 0.04% | +53.6% |
| Q4 2019 | $286,000 | +28.8% | 2,747 | +22.9% | 0.03% | +64.7% |
| Q3 2019 | $222,000 | -48.5% | 2,235 | -34.8% | 0.02% | -29.2% |
| Q1 2019 | $431,000 | +103.3% | 3,429 | +119.1% | 0.02% | +118.2% |
| Q4 2018 | $212,000 | -37.3% | 1,565 | +27.1% | 0.01% | -47.6% |
| Q3 2018 | $338,000 | +11.2% | 1,231 | -44.6% | 0.02% | +31.2% |
| Q4 2017 | $304,000 | -62.2% | 2,222 | -62.4% | 0.02% | -60.0% |
| Q3 2017 | $805,000 | – | 5,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |